[CLDX] QoQ Quarter Result on 30-Sep-2014 [#Q3]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
05-Nov-2014
Financial Year
2014
Quarter
30-Sep-2014 [#Q3]
Profit Trend
QoQ- 0.68%
YoY- -21.36%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Revenue 2,178 486 1,477 1,101 592 416 620 131.62%
PBT -32,359 -30,174 -31,821 -28,082 -28,274 -29,903 -22,062 29.18%
Tax -782 -1,614 -229 -2,260 -275 -1,586 -137 220.41%
NP -32,359 -30,174 -31,821 -28,082 -28,274 -29,903 -22,062 29.18%
Tax Rate - - - - - - - -
Total Cost 34,537 30,660 33,298 29,183 28,866 30,319 22,682 32.45%
Ratio Analysis
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
NP Margin -1,485.72 -6,208.64 -2,154.43 -2,550.59 -4,776.01 -7,188.22 -3,558.39 -44.22%
Per Share
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
EPS -4.93 -4.90 -5.33 -4.71 -4.75 -5.02 -3.71 20.93%
EPS Diluted -4.93 -4.90 -5.33 -4.71 -4.75 -5.02 -3.71 20.93%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.